Evidence map›Paper›PMID 42266879›Full record

ArticleFrontiers in artificial intelligence2026

Ensemble Deep Learning Denoising (EDLD) model and optimized OTSU segmentation for Alzheimer's disease diagnosis using MRI images.

S Amuthan, N C Senthilkumar

Abstract read
In one paragraph

Article in Frontiers in artificial intelligence, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

S AmuthanSchool of Computer Science Engineering and Information Systems, Vellore Institute of Technology, Vellore, India.
N C SenthilkumarSchool of Computer Science Engineering and Information Systems, Vellore Institute of Technology, Vellore, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Diagnosing Alzheimer's disease (AD) is necessary to determine treatment options. AD categorization using machine learning (ML) relies on difficult, manually specified features. The most important stage in AD diagnosis is denoising to restore image stability and quality. An ensemble image denoising technique that combines Attention Guided Convolutional Neural Network (AGCNN), Adaptive Denoising Autoencoder (ADAE), and Gaussian Deep Belief Network (GDBN) improves image denoising performance. The hybrid AGCNN reduces noise and aligns along the global route by combining global and local characteristics. In ADAE, the encoder learns picture representations using convolutional layers (CLs) while the decoder uses deconvolutional layers. In addition, the GDBN extends the standard Deep Belief Network (DBN) to Gaussian Restricted Boltzmann Machines (RBMs). Ensemble learning selects the approach with the greatest Peak Signal-to-Noise Ratio (PSNR) to integrate learning outcomes. After separating the background from the foreground by calculating the variances within the two groups, OTSU determines the threshold that minimizes the weighted sum of the variances. Levy Grasshopper Optimization Algorithm (LGOA) optimizes threshold selection by mimicking grasshopper swarming. VGG16, the DCNN model, is pre-trained for Alzheimer's datasets. The results are Sensitivity (SEN -95.86%), specificity (SPC - 94.93%), precision (PPV - 94.55%), F1-score (F1 - 95.21%), accuracy (ACC -95.87%), and Area Under the Receiver Operating Characteristic Curve (AUC - 96.45%) assess system and method performance.

Indexed as

Adaptive Denoising Autoencoder (ADAE)Alzheimer's diseaseAttention Guided Convolutional Neural Network (AGCNN)brain MRI imagesDeep Convolutional Neural Network (DCNN)deep learningGaussian Deep Belief Network (GDBN)stage prediction

Identifiers

PMID42266879
PMCPMC13243433

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.